Right now the price per share is 0,38$, NeuBase Therapeutics Inc, with address at 700 TECHNOLOGY DRIVE, PITTSBURGH, Pennsylvania, 15219, United States, is a publicly traded company and its visible heads at the moment are Anthony Rossomando (Chief Technology Officer), Curt W. Bradshaw (Chief Scientific Officer), Dietrich A. Stephan (Chairman, President, CEO & Chief Financial Officer), Robert Friedlander (Chief Medical Officer), Sandra Porcile Rojas-Caro (Chief Medical Officer), William R. Mann (Chief Operating Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 0,38$ moving between 0,37$ and 0,39$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
